Connect with us
PharmaMar's profits rebound with a 64% increase to 2.3 million euros in Q1 2024 compared to the same period last year. Total revenues dropped by 19.45%...
Grifols reports positive results from its Phase IV study of Fanhdi for von Willebrand disease (VWD) treatment, showing safety and efficacy. Presented at the 2024 World...
Vithas and MSD have formed an alliance to enhance patient care, especially in cancer treatment. The collaboration focuses on innovation, research, and education, coinciding with the...
In 2022, spending on biotechnology Research and Development (R&D) increased by 13% to reach 2.56 billion euros. Company expenditure grew by 17.8%, accounting for 47.7% of...
The AI boom extends to mental health, with startups emerging in Spain aiming to leverage technology for patient and professional benefits. Solutions like MoodCapture detect mental...
Vytrus Biotech's first-quarter 2024 sales surged by 32% compared to 2023, driven by skin and hair care products. The US and European markets led the growth,...
Vertex announced plans to acquire Alpine Immune Sciences for $4.9 billion, primarily for its experimental drug povetacicept to treat IgA nephropathy. Vertex will pay $65 per...
Reig Jofre invests €5.8 million in Leanbio for vertical integration in biotechnology. They increase their stake to 24%, committing to expanding further. The collaboration aims to...
Johnson & Johnson announces the acquisition of Shockwave Medical for $13.1 billion, expanding its presence in cardiovascular intervention. Subject to shareholder and regulatory approval, the deal...
Grifols leads the IBEX 35's mid-morning gains, rising 3.42% to 9.02 euros, marking its fourth consecutive positive day. Despite falling over 40% for the year, the...